Experts Applaud, Question President’s Pledge to End AIDS Epidemic
Experts Applaud, Question President’s Pledge to End AIDS Epidemic
Donald Trump announced a plan to drastically cut HIV transmission by 2030, but some scientists and nonprofits aren’t sure the administration will follow through.
Experts Applaud, Question President’s Pledge to End AIDS Epidemic
Experts Applaud, Question President’s Pledge to End AIDS Epidemic

Donald Trump announced a plan to drastically cut HIV transmission by 2030, but some scientists and nonprofits aren’t sure the administration will follow through.

Donald Trump announced a plan to drastically cut HIV transmission by 2030, but some scientists and nonprofits aren’t sure the administration will follow through.

HIV prevention
Why an HIV Vax Only Works for Some
Why an HIV Vax Only Works for Some
Anna Azvolinsky | Jul 15, 2015
Scientists identify a human leukocyte antigen gene linked to immune protection from HIV following vaccination.
HIV in the Internet Age
HIV in the Internet Age
Jef Akst | May 1, 2015
Social networking sites may facilitate the spread of sexually transmitted disease, but these sites also serve as effective education and prevention tools.
Opinion: The Murky World of Medical Ethics
Opinion: The Murky World of Medical Ethics
Nathalia Holt | Aug 7, 2014
Why are researchers still denying some study participants potentially life-saving therapies?
Week in Review: April 1-5
Week in Review: April 1-5
Jef Akst | Apr 5, 2013
Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine
Bee Venom for HIV Prevention
Bee Venom for HIV Prevention
Edyta Zielinska | Mar 12, 2013
Nanoparticles coated with a toxin found in bee venom can destroy HIV while leaving surrounding cells intact.
HIV Prevention Drug Approved
Hayley Dunning | Jul 17, 2012
The FDA approves the use of Truvada for those at high risk of HIV infection.
HIV Prevention Debate
Cristina Luiggi | May 21, 2012
The suggested approval of a widely used antiretroviral drug to prevent HIV transmission in uninfected people sparks a debate about the possible dangers of such a move.